HPLC & MS verified
Independently tested by Janoshik Analytical for purity and identity. Reports are published in the COA library as each batch is verified — how we test.
Exact peptide content
Net peptide weight and sequence are listed per vial — not just a total weight that includes salts and moisture.
Built to be researched
A reconstitution calculator with vial and syringe visuals, plus an interaction checker, sit next to the products.
Domestic AU & NZ dispatch
Shipped from domestic stock in both Australia and New Zealand — no customs holds or overseas lead times.
Transparent
Trusted
Full range
Research compounds. Real data. One place.
Useful tools. Real information.
A healthier tomorrow.
Explore mechanistic overlap, pathway relationships and the research evidence behind multi-compound combinations. This tool does not answer whether a combination is safe, effective or advisable — it maps what is mechanistically known and what has (and hasn’t) actually been studied.
—
—
This performs unit conversion on the numbers you enter only — it does not recommend a dose or a vial size. For laboratory and research use; not a substitute for professional guidance.
See where each compound sits in published research and clinical development — not the regulatory status of any Vital Edge Science product, and not a recommendation, efficacy claim or dosing guidance.
| Compound | Research line | Research status | Development note | |
|---|---|---|---|---|
| 5-Amino-1MQ | Ignite | Preclinical | Cellular and animal research | View → |
| BPC-157 | Rebuild | Preclinical | Predominantly preclinical research | View → |
| CJC-1295 | Peak | Human Research | Early/historical clinical research | View → |
| Cagrilintide | Ignite | Phase 3 | Active clinical development | View → |
| DSIP | Neuro | Human Research | Historical human research | View → |
| Epithalon | Rebuild | Human Research | Limited/historical human research | View → |
| GHK-Cu | Rebuild | Human Research | Translational/human research | View → |
| GHRP-2 | Peak | Human Research | Experimental endocrine research | View → |
| Glutathione | Rebuild | Human Research | Extensive human literature | View → |
| HCG | Ignite | Approved Molecule* | Established medicine | View → |
| Ipamorelin | Peak | Human Research | Human pharmacology/clinical research | View → |
| KPV | Rebuild | Preclinical | Cellular and animal research | View → |
| Kisspeptin-10 | Enhance | Human Research | Active experimental human research | View → |
| MOTS-c | Ignite | Phase 2a | Early clinical investigation | View → |
| Melanotan I | Enhance | Approved Molecule* | Established pharmaceutical ingredient | View → |
| Melanotan II | Enhance | Human Research | Early/historical human research | View → |
| NAD+ | Ignite | Human Research | Broad translational research | View → |
| PT-141 | Enhance | Approved Molecule* | Established pharmaceutical ingredient | View → |
| Retatrutide | Ignite | Phase 3 | Active clinical development | View → |
| SS-31 | Rebuild | Approved Molecule* | Accelerated approval / confirmatory research ongoing | View → |
| Selank | Neuro | Human Research | Limited/regional clinical research | View → |
| Semaglutide | Ignite | Approved Molecule* | Extensive clinical development | View → |
| Semax | Neuro | Human Research | Limited/regional clinical research | View → |
| Sermorelin | Peak | Human Research | Extensive historical human research | View → |
| Tesamorelin | Peak | Approved Molecule* | Established pharmaceutical ingredient | View → |
| Thymosin Alpha-1 | Rebuild | Phase 3 | Indication-specific clinical development | View → |
| Thymosin Beta-4 (TB-4) | Rebuild | Phase 2 | Human clinical research | View → |
| Tirzepatide | Ignite | Approved Molecule* | Ongoing clinical research | View → |
Limited/historical human research
View research →Active experimental human research
View research →Established pharmaceutical ingredient
View research →Early/historical human research
View research →Established pharmaceutical ingredient
View research →Accelerated approval / confirmatory research ongoing
View research →Established pharmaceutical ingredient
View research →Indication-specific clinical development
View research →*Approval refers to specific pharmaceutical products, formulations, jurisdictions and indications containing this molecule. It does not indicate that the Vital Edge Science research product is approved.
Every report, on file.
Testing is via Janoshik Analytical. Reports are added here as each batch is verified — not every product has a report on file yet. Read how we test.
| Compound | Lot | |
|---|---|---|
| Retatrutide (10mg) | Batch 4 (10mg — full 6-panel) | Purity and Identification Endotoxin Heavy Metal LC-MS TFA Sterility |
| Retatrutide (30mg) | Batch 2 (30mg) | Purity/ID report |
| BPC-157 | Batch 3 | Purity/ID report |
| GHK-Cu | Batch 2 | Purity and Identification Endotoxin Heavy Metal |
| Thymosin Beta-4 (TB-4) | Batch 2 | Purity/ID report |
| Ipamorelin | Batch 2 | Purity/ID report |
| Melanotan II | Batch 2 | Purity/ID report |
| CJC-1295 | Batch 2 | Purity/ID report |
| MOTS-c | Batch 2 | Identity and Purity Endotoxin Heavy Metals |
| Melanotan I | Batch 1 | Purity/ID report |
| Tesamorelin | Batch 2 | Janoshik purity/ID report |
| Tirzepatide | Batch 1 | Purity/ID report |
| KPV | Batch 2 | Purity/ID report |
| Semax | Batch 2 | Purity/ID report |
| Selank | Batch 2 | Purity/ID report |
| PT-141 | Batch 2 | Purity/ID report |
| Epithalon | Batch 2 | Purity/ID report |
| DSIP | Batch 1 | Janoshik purity/ID report |
Verified third-party reviews
See what real customers say about their experience with Vital Edge Science.